Golden
Insilico Medicine

Insilico Medicine

Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases

Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases. The company was founded by Alex Zhavoronkov in 2014, in Rockville, Maryland, United States.



The company looks to extend deep learning and artificial intelligence solutions for drug and aging research. The company provides 3D molecular representations based on the wave transform for Convolution Neural Networks Molecular pharmaceutics. Insilico Medicine's drug discovery engine utilizes millions of samples and multiple data types to discover signatures of disease and to identify targets for molecules that exist or can be generated.



The company looks to launch research and development centers and research results in Taiwan. Their team consists of scientists that operate in the United States, United Kingdom, Poland, Belgium, South Korea, Taiwan, Africa, and Russia.



COVID-19



In response to the outbreak of coronavirus (COVID-19), the company has offered support to discover drugs. They have been working on research with six molecules to combat the virus. Insilico Medicine is using their AI-based drug discovery pipeline to identify drug molecules that could target 3C-like protease. 3C-like protease is a SARS-CoV-2 protein that is a target for potential drugs because it has a central role in the viral replication cycle. A portion will be tested by Insilico Medicine and the remainder of the potentially useful structures will be published on the company website and available to the public (https://insilico.com/ncov-sprint/).









Timeline

September 2019

Insilico Medicine raises a $37,000,000 series B round from F-Prime Capital Partners, Pavilion Capital, Baidu Ventures, Eight Roads Ventures, Bold Capital Partners, Juvenscence, Lilly Asia Ventures, Sinovation Ventures and QiMing Venture Partners.

People

Name
Role
LinkedIn

Alex Aliper

Employee



Alex Zhavoronkov

Founder



Alexander H. Perkins

Employee



Artem V. Artemov

Employee



Eli Mohamad

Employee



Elizabeth Galbut

Investor



Eugene Makarev

Employee



Eugeniya Cheskidova

Employee



Evgeny Putin

Employee



Ivan Ozerov

Employee



Jane Schastnaya

Employee



Ksenia Lezhnina

Employee



Marine Bozdaganyan

Employee



Matthew Gorra

Attorney



Mikhail KORZINKIN

Employee



Polina Mamoshina

Employee



Qingsong Zhu

Employee



Quentin Vanhaelen

Employee



Further reading

Title
Author
Link
Type
Date

Insilico Medicine



Web



Insilico Medicine



Web



Potential COVID-2019 3C-like Protease Inhibitors Designed Using Generative Deep Learning Approaches



Web







Auto-extract from URL...









Auto-extract from URL...





Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services

Insilico Medicine

Alex Zhavoronkov

Rockville, Maryland, United States

Medical products, DNA

News

Title
Author
Date
Publisher
Description
Miles Goscha
October 10, 2019
TechNode
Artificial intelligence is proving useful in streamlining health-related research processes and accelerating drug development.

References